Table 4. Unadjusted and adjusted effects of infant acetaminophen use on childhood asthma and related phenotypes.
Odds ratios: | |||||||
Outcome | N | Unadj. | (95% CI) | P | Adj.* | (95% CI) | P |
Asthma | 7735 | 1.19 | (1.08, 1.32) | <.001 | 1.11 | (1.00, 1.23) | .046 |
Wheezing | 7821 | 1.20 | (1.08, 1.34) | <.001 | 1.12 | (1.00, 1.25) | .045 |
Eczema | 7809 | 1.09 | (1.00, 1.18) | .06 | 1.05 | (0.97, 1.15) | .23 |
Atopy | 6092 | 1.15 | (1.05, 1.26) | .002 | 1.14 | (1.04, 1.25) | .005 |
Geometric mean ratios: | |||||||
Outcome | N | Unadj. | (95% CI) | P | Adj.* | (95% CI) | P |
BHR slope | 4118 | 1.07 | (1.00, 1.15) | .06 | 1.04 | (0.97, 1.12) | .3 |
Total IgE | 4812 | 0.99 | (0.93, 1.06) | .88 | 0.97 | (0.90, 1.03) | .32 |
Arithmetic mean differences: | |||||||
Outcome | N | Unadj. | (95% CI) | P | Adj.* | (95% CI) | P |
Adjusted FVC (SDs) | 6327 | -0.01 | (-0.04, 0.03) | .7 | -0.01 | (-0.04, 0.03) | .69 |
Adjusted FEV1 (SDs) | 6231 | 0.00 | (-0.03, 0.04) | .8 | 0.01 | (-0.03, 0.04) | .66 |
Adjusted FEF25-75 (SDs) | 6327 | 0.00 | (-0.03, 0.04) | .81 | 0.01 | (-0.03, 0.04) | .69 |
Adjusted for maternal factors in pregnancy (smoking, infections, anxiety score, acetaminophen and antibiotic use, alcohol intake); other maternal factors (educational level, housing tenure, financial difficulties, body mass index, ethnicity, age, parity, history of asthma, eczema, rhinoconjunctivitis, migraine); sex of child, season of birth, multiple pregnancy, gestational age, birthweight, head circumference, birth length; postnatal factors (breast feeding, day care, pets, damp/mould, environmental tobacco smoke exposure, number of younger siblings, infant antibiotic use, BMI at age 7).